Backward: GSK-2636771 (1372540-25-4)

GSK-2636771

Catalog Selection !
Search by Name, CAS or Alsachim Id
   

Search by Name, CAS or Alsachim Id



GSK-2636771


GSK-2636771 (1372540-25-4)

CAS Number: 1372540-25-4
Product Number: C5868
Molecular Formula: C22H22F3N3O3
Molecular Weight: 433.42 g.mol-1
Family: Drugs standards & API References

Specifications:
Minimum purity: 98.0 %
Appearance: White to off-white powder
Solubility: Soluble in Dimethyl sulfoxide
Catalog Quantity: 10 mg, 25 mg, 50 mg, 100 mg

HS Code: 291639

Last review: Monday 23rd February 2015

GSK-2636771 (1372540-25-4)

GSK-2636771
or 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid
or GSK-2636771


CAS Number: 1372540-25-4
Product Number: C5868
Molecular Formula: C22H22F3N3O3
Molecular Weight: 433.42 g.mol-1
Family: Drugs standards & API References

Specifications:
Minimum purity: 98.0 %
Appearance: White to off-white powder
Solubility: Soluble in Dimethyl sulfoxide
Catalog Quantity: 10 mg, 25 mg, 50 mg, 100 mg

HS Code: 291639

Last review: Monday 23rd February 2015
GSK-2636771 (1372540-25-4)

GSK-2636771 (1372540-25-4) GSK-2636771 (1372540-25-4)
GSK-2636771 (1372540-25-4)
GSK-2636771 (CAS: 1372540-25-4) - GSK-2636771 or 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid

Keywords : Internal standard GSK-2636771, HPLC-MS method validation GSK-2636771, LC-MS-MS method validation GSK-2636771, Deuterated internal standard GSK-2636771, Deuterated GSK-2636771, Deuterium labeled GSK-2636771, Quantitative bioanalytical methods GSK-2636771, Blood samples GSK-2636771, Analysis GSK-2636771, Clinical diagnostic GSK-2636771, Dosing GSK-2636771

If you find that a product is not part of our current offering,
we strongly encourage you to place a request for a quotation nonetheless.